GSM gold starGSM Global
中文版 · Chinese

Bavarian Nordic Third-Quarter Revenue of DKK 1,805 Million: Travel Health Revenue Rose 22 Percent to DKK 1,144 Million With an EBITDA Margin of 34.4 Percent, Released November 13

Saturday, November 14, 2026 · Finance · GSM News

Vaccine company Bavarian Nordic announced its interim financial results for the third quarter and first nine months of 2026 on November 13, 2026. All figures below are from the body of the company's results release, and this report offers no investment advice.

Revenue in the third quarter was DKK 1,805 million, compared to DKK 1,795 million in the third quarter of 2025.

Travel Health revenue increased by 22 percent, or 32 percent when adjusting for discontinued partnerships, to DKK 1,144 million, primarily driven by continued strong RabAvert and Rabipur sales of DKK 886 million, up 37 percent, and supported by the continued launch of Vimkunya at DKK 73 million, up 146 percent. Public Preparedness revenue reached DKK 606 million in the quarter.

EBITDA in the third quarter was DKK 621 million, corresponding to an EBITDA margin of 34.4 percent. Total revenue for the first nine months was DKK 4,897 million, an increase of 2 percent. The company maintained its upgraded full-year guidance, expecting total revenue of approximately DKK 6,100 million and an EBITDA margin of approximately 32 percent.

Source: Bavarian Nordic

Published by GSM · USA (original Chinese edition)

Photo: 图:Bavarian Nordic相关图(资料图)。作者与授权:Jacob van Ruisdael,Public domain,维基共享资源。 / Photo: Image related to Bavarian Nordic (file photo). Credit: Jacob van Ruisdael, Public domain, Wikimedia Commons.

Latest in Finance